Company Profile
LeMaitre Vascular Stock Price, News & Catalysts
- Ticker:
- LMAT
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
82.51 USD (+0.16%)
Close
Last updated: August 17, 2026
2.09B USD
Market cap
Why the stock is moving
As of Aug 17, 2026, LMAT was little changed and closed at $82.51. No new same-company headline was identified in the current news window.
Company overview
Business overview
LeMaitre Vascular is a medical device company serving vascular surgeons with implants, grafts, and related products. The business is rooted in procedure-linked vascular care.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, LeMaitre sits in niche medtech.
Business Model Characteristics
Revenue comes from surgeon adoption, recurring product use, and steady growth in vascular procedures.
Position Within the Biotechnology Landscape
LeMaitre is a disciplined medtech name that trades on procedural demand and product execution rather than biotech catalysts.
Future catalysts
- LeMaitre's catalysts are vascular-graft demand, biologic patch adoption, and product-cycle execution in specialty surgery. The stock improves when recurring demand stays steady.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of LeMaitre Vascular (LMAT)?
LeMaitre Vascular (LMAT) most recently closed at 82.51 USD, a +0.16% move versus the previous session.
What is the market cap of LeMaitre Vascular (LMAT)?
LeMaitre Vascular currently has a market capitalization of 2.09B USD on BioPharmSignal.
What does LeMaitre Vascular do?
LeMaitre Vascular is a medical device company serving vascular surgeons with implants, grafts, and related products. The business is rooted in procedure-linked vascular care.
On which exchange is LMAT stock listed?
LeMaitre Vascular (LMAT) is associated with NASDAQ, United States, Biopharma.
What is LeMaitre?
LeMaitre's catalysts are vascular-graft demand, biologic patch adoption, and product-cycle execution in specialty surgery.
Which conditions is LeMaitre Vascular targeting with LeMaitre?
LeMaitre's catalysts are vascular-graft demand, biologic patch adoption, and product-cycle execution in specialty surgery.
How does LeMaitre Vascular describe recent progress with LeMaitre?
LeMaitre's catalysts are vascular-graft demand, biologic patch adoption, and product-cycle execution in specialty surgery.
What is Vascular?
LeMaitre Vascular is a medical device company serving vascular surgeons with implants, grafts, and related products.